Collplant biotechnologies to present on the use of collagen bioink as a platform for 3d bioprinting of tissues and organs at the biomaterials for 3d printing webinar

Rehovot, israel, aug. 16, 2021 /prnewswire/ - collplant (nasdaq: clgn), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that dr. nadav orr, vice president of r&d, will present on august 19, 2021, an overview on the use of collagen bionks for 3d bioprinting, during the biomaterials for 3d printing webinar by 3dheals llc.  the presentation is titled "collagen bioink platform for 3d bioprinting of tissues and organs.
CLGN Ratings Summary
CLGN Quant Ranking